Analyzing the options chain and the chart patterns of SIGA Technologies prior to the earnings report this week, I would consider purchasing the 5usd strike price Calls with an expiration date of 2024-6-21, for a premium of approximately $0.50. If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
As shown on the daily chart dating back to last summer SIGA has been on a persistent decline since the cooling down from the parabolic breakout last summer. Is there a repeat in the picture? Fundamentally, earnings continue to be weak. much of the stock is held by insiders and the whole monkey pox thing is settled down although the main product may have use...
$SIGA followed my chart very precisely and hit my short target💪 I just noticed that $SIGA actually forming a Bump and Run bearish pattern and it could dip even lower to $8-8.60 If it holds above the trendline and volume increases, this pattern may be invalid...
Very interesting level here for SIGA. Not rushing into anything but if we can get this yellow level to hold as support and push higher. Could be a great long term entry. Massive move down with no relief on the way down at all. With a massive level like this it could be a great opportunity for a swing
$CBIO looks like it has potential to make a large move soon, Also it's #4 in list of top Fintel Gamma Squeeze list📈
Daily closed above major resistance, this might lead it to continue the rally in the coming weeks 🔥
Break above this bull flag will lead the price to reach a new ATH
Hype and sentiment regarding a monkeypox outbreak has been the only driver in SIGAs price, apart from minor PR. Volume will slowly wither away, and investors will begin to take profits. It will not remain at this price range for much longer. Looks to be an easy short/put. Will be opening 10$ Puts with a June 17th expiry.
New York-based pharmaceutical firm SIGA Technologies (NASDAQ:SIGA) is among the companies to benefit from the growing threat of monkeypox, recently pushing its shares to an almost decade-high after the company obtained approval in Europe to use its TPOXX antiviral drug for the treatment of monkeypox. Smallpox jabs vs monkeypox On May 19, the World Health...
Price on this Monthly timeframe is respecting this Gaussian Channel indicator at the upper band Constant bull rejections has ultimately lead to the current break out we see today